Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Clinical Journal of the American Society of Nephrology : CJASN|July 26, 2011
Vision-threatening retinal abnormalities in chronic kidney disease stages 3 to 5Rajeev Deva, Mohamad Afzal Alias, Deb Colville, et al.
Clinical Chemistry|June 6, 2014
Use of copy number deletion polymorphisms to assess DNA chimerismDamien L Bruno, Devika Ganesamoorthy, Natalie P Thorne, et al.
Kidney International|May 24, 2025
A randomized controlled trial of intravenous immunoglobulin vs standard of care for the treatment of chronic active antibody-mediated rejection in kidney transplant recipientsWilliam R Mulley, Dhakshayini Tharmaraj, Kevan R Polkinghorne, et al.
Bioresearch Open Access|March 22, 2013
Abnormal Processing of Autophagosomes in Transformed B Lymphocytes from SCARB2-Deficient SubjectsKurt Gleich, Michael J Desmond, Darren Lee, et al.
JACC. Cardiovascular Interventions|January 15, 2025
Early and Late Outcomes With the Absorb Bioresorbable Vascular Scaffold: Final Report From the ABSORB Clinical Trial ProgramDavid A Power, Anton Camaj, Dean J Kereiakes, et al.
Blood Purification|January 23, 2020
A tRial Evaluating Mid Cut-Off Value Membrane Clearance of Albumin and Light Chains in HemoDialysis Patients: A Safety Device StudyRathika Krishnasamy, Carmel M Hawley, Meg J Jardine, et al.
Trials|May 27, 2020
Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantationMichael G Collins, Magid A Fahim, Elaine M Pascoe, et al.
The American Journal of Cardiology|January 21, 2022
Effect of Elevated C-Reactive Protein on Outcomes After Complex Percutaneous Coronary Intervention for Angina PectorisAnton Camaj, Gennaro Giustino, Nikola Kocovic, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|March 29, 2021
Effect of a medium cut-off dialyzer on protein-bound uremic toxins and mineral metabolism markers in patients on hemodialysisMark K Tiong, Rathika Krishnasamy, Edward R Smith, et al.
Diabetes|March 11, 2022
Independent of Renox, NOX5 Promotes Renal Inflammation and Fibrosis in Diabetes by Activating ROS-Sensitive PathwaysJay C Jha, Aozhi Dai, Jessica Garzarella, et al.
Pageof 9